hdl therapeutics – Hdl Therapeutics, Inc. Investor Rights Agreement (April 12th, 2013)
THIS INVESTOR RIGHTS AGREEMENT (the Agreement) is entered into as of the 28th day of April 2008, by and among HDL Therapeutics, Inc., a Delaware corporation (the Company) and the investors listed on Exhibit A hereto, referred to hereinafter as the Investors and each individually as an Investor.
Consent and Waiver Agreement (November 15th, 2007)
THIS CONSENT AND WAIVER AGREEMENT (this "Agreement") is made as the 7th day of November, 2007, by and among INTERPHARM HOLDINGS, INC., a Delaware corporation (the "Company"), TULLIS-DICKERSON CAPITAL FOCUS III, L.P., a Delaware limited partnership ("Tullis"), AISLING CAPITAL II, LP, a Delaware limited partnership ("Aisling"), P&K HOLDINGS I, LLC ("P&K Holdings"), a New York Limited Liability Company, RAMETRA HOLDINGS I, LLC ("Rametra Holdings"), a New York Limited Liability Company, RAJS HOLDINGS I, LLC ("Rajs Holdings" and, together with P&K Holdings, Perry Sutaria, Raj Sutaria and Rametra Holdings, the "Sutaria Stockholders"), a New York Limited Liability Company, PERRY SUTARIA ("PS"), individually and as Manager of the Sutaria Stockholders, RAJ SUTARIA ("RS"), individually, and CAMERON REID ("Reid"), individually. Capitalized terms in the Recitals hereto and not defined
Securities Purchase Agreement (November 15th, 2007)
THIS PURCHASE AGREEMENT ("Agreement") is made as of the 14th day of November, 2007 by and among Interpharm Holdings Inc., a Delaware corporation (the "Company"), Interpharm, Inc., a New York corporation (the "Interpharm" and together with the Company, the "Borrowers") and the Purchasers set forth on the signature page affixed hereto (each a "Purchaser" and collectively the "Purchasers").